MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F9 (formerly 1F9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Products
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI6C6 (formerly 6C6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7B1 (formerly 7B1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Recombinant protein of human mitogen-activated protein kinase kinase 1 (MAP2K1), 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human mitogen-activated protein kinase kinase 1 (MAP2K1), 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human mitogen-activated protein kinase kinase 1 (MAP2K1 mutant D67N), with C-terminal MYC/DDK tag, expressed in human cells, 20ug
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
MAP2K1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Transient overexpression lysate of mitogen-activated protein kinase kinase 1 (MAP2K1)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression of MAP2K1 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Clonalities
Assay Types
Brands
QC Levels
Pathways
- Acute myeloid leukemia (102)
- B cell receptor signaling pathway (102)
- Bladder cancer (102)
- Chemokine signaling pathway (102)
- Chronic myeloid leukemia (102)
- Colorectal cancer (102)
- Dorso-ventral axis formation (102)
- Endometrial cancer (102)
- ErbB signaling pathway (102)
- Fc epsilon RI signaling pathway (102)
- Fc gamma R-mediated phagocytosis (102)
- Focal adhesion (102)
- Gap junction (102)
- Glioma (102)
- GnRH signaling pathway (102)
- Insulin signaling pathway (102)
- Long-term depression (102)
- Long-term potentiation (102)
- MAPK signaling pathway (102)
- Melanogenesis (102)
- Melanoma (102)
- Natural killer cell mediated cytotoxicity (102)
- Neurotrophin signaling pathway (102)
- Non-small cell lung cancer (102)
- Oocyte meiosis (102)
- Pancreatic cancer (102)
- Pathways in cancer (102)
- Prion diseases (102)
- Progesterone-mediated oocyte maturation (102)
- Prostate cancer (102)
- Regulation of actin cytoskeleton (102)
- Renal cell carcinoma (102)
- T cell receptor signaling pathway (102)
- Thyroid cancer (102)
- Toll-like receptor signaling pathway (102)
- VEGF signaling pathway (102)
- Vascular smooth muscle contraction (102)
